U.S. Online Retail and Ecommerce Stock News

Key Insights Using the 2 Stage Free Cash Flow to Equity, Blue Bird fair value estimate is US$94.98 Blue Bird is...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Institutions' substantial holdings in Rayonier Advanced Materials implies that they have significant...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stitch Fix fair value estimate is US$6.57 Stitch Fix is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

With a price-to-earnings (or "P/E") ratio of 27x Element Solutions Inc ( NYSE:ESI ) may be sending bearish signals at...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

American Financial Group, Inc.'s ( NYSE:AFG ) dividend will be increasing from last year's payment of the same period...

If you have been watching ThredUp lately, you know it is one of those rare stocks that keeps drawing your attention. Whether you are holding after that massive 1-year surge or you are still weighing your next move, there is a lot to unpack. ThredUp has soared an eye-catching 1111.0% over the last year, with a staggering 568.8% gain year-to-date. Even after a recent 30-day dip of -10.7%, it has still notched a respectable 2.4% gain in the past week. This reminds investors that volatility can...

Ovid Therapeutics recently announced positive topline results from its Phase 1 study of OV329, a next-generation GABA-aminotransferase inhibitor targeting drug-resistant epilepsies, demonstrating significant GABAergic inhibition and strong safety outcomes in 68 healthy volunteers. This clinical milestone signals potential advancement in the treatment of drug-resistant epilepsies and attracted new institutional investors through a substantial private placement. We'll explore how OV329’s early...

Thinking about what to do with Globe Life stock? You are definitely not alone. Friends and clients keep asking whether it is the right time to get in, stay patient, or take some profits. Globe Life’s price has had its share of twists lately, most notably a dip of 4.8% in the last week and 2.1% across the past month. Yet, look a little further back and things get more interesting. The stock’s up a strong 22.6% so far this year and an impressive 30.2% over the last twelve months. That kind of...

On September 24, 2025, Zura Bio Limited adopted an Executive Severance Benefit Plan, outlining compensation for executives if terminated without cause or upon resignation for good reason, especially in the context of a change in control. This move comes as the company, which reported having US$154 million in cash with a reported runway of 3.5 years as of June 2025, faces scrutiny over its increasing cash burn and potential funding needs. We'll examine how concerns around Zura Bio's executive...

If you’ve been scanning the markets wondering whether now is the right time to buy, hold, or move on from Alexander & Baldwin, you’re not alone. This stock can puzzle even seasoned investors, especially after a rollercoaster of performance. Over the past five years, Alexander & Baldwin’s price has soared nearly 80%, which is impressive for a real estate-focused name. Those who’ve sat tight since 2021 are still up over 22% despite the flat year-over-year returns, and a slight dip of -0.4% in...

Thinking about what to do with Zurn Elkay Water Solutions stock? You are not alone. Investors have watched this water solutions company steadily climb, with shares up 4.9% in the last 30 days and a whopping 29.9% over the past year. The longer-term numbers are even more eye-catching, showing a return of 96.6% over three years and a stunning 217.9% run across five years. After a quieter week, with the stock up just 0.1%, some might wonder if the stock is catching its breath for another sprint...

Thinking about what to do with Bright Horizons Family Solutions stock? You're not alone. Whether you already have shares or you’re just getting curious about this company, it’s one of those stocks that invites a lot of questions about whether it’s undervalued, expensive, or maybe somewhere in between. Over the past year, the stock has dropped nearly 22%, which feels like a steep slide. But if we zoom out, you’ll notice it’s actually up more than 88% over the last three years, even after a...

If you are wondering what to do next with Guardian Pharmacy Services stock, you are in good company. With its shares closing at $23.94 and a one-year return of 37.9%, the company has caught plenty of attention from investors seeking growth. The start of the year brought optimism, with the stock up 20.4% year-to-date, but the past month has tested that resolve, as the price dropped 15.7% in the last 30 days and 8.0% over the past week. This recent dip may stir anxiety or curiosity, depending...

If you’ve been watching Steelcase stock lately, you’re not alone. Whether you’re wondering if now is the time to buy, hold, or cash in some gains, there’s plenty to consider. After notching a 0.7% gain in just the last week, and more than doubling investors’ money over the past three years with a 171.5% return, Steelcase has certainly caught the market’s attention. That momentum is not just a blip; with a 47.6% gain year-to-date, the company’s upward move reflects both a renewed sense of...

Petco Health and Wellness Company (WOOF) stock has caught the attention of investors as it navigates recent market movements. The company's share price has changed over the past month, offering fresh insight into how the market views its outlook. See our latest analysis for Petco Health and Wellness Company. Momentum for Petco Health and Wellness Company has faded, with the share price edging only slightly higher in recent months and the 1-year total shareholder return down nearly 29%. Recent...

Thinking about what to do with Otter Tail shares? You’re not alone. The stock’s recent movements have left many investors weighing their options and wondering whether this utility powerhouse still has room to run. While there’s been a bit of short-term turbulence, with the stock down 3.3% over the past week and off 4.8% for the last month, stepping back reveals a very different picture. Year-to-date, the stock still sits up 10.1%, and if you’ve been holding for the long haul, you’re looking...

If you are trying to figure out what to do with Hanesbrands stock right now, you are definitely not alone. The conversation has heated up again, spurred by news that Gildan Activewear is reportedly eyeing a takeover at about $6 per share. This sort of bid inevitably shines a spotlight on Hanesbrands’ fundamentals, forcing investors to re-evaluate both the risks and the upside, especially since the stock closed most recently at $6.90. In the last week, Hanesbrands saw a tidy 4.7% gain,...

BGSF, Inc. ( NYSE:BGSF ), might not be a large cap stock, but it saw significant share price movement during recent...

Key Insights Given the large stake in the stock by institutions, GigaCloud Technology's stock price might be vulnerable...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...